Genting SP: Black candle.

Has Genting SP's sky rocketing price run out of fuel at last? The price action is still above the upper Bollinger band and there is much room to fall in case of a pull back to the 20dMA, currently at $1.30. This is also a candlestick resistance level which took many sessions to be overcome.  This price is therefore psychologically stronger in the minds of market participants and should be a strong support.

Overall, momentum is still positive.  The higher low on the MFI suggests that demand is still intact.  This is despite some distribution taking place as suggested by the OBV turning down.

However, the price has moved up too quickly as suggested by the RSI which is in the overbought territory and this is being corrected.  All signs currently suggest that Genting SP's share price might just be taking a breather.

Healthway Medical: 17c support.

Some large transactions sold down shares of Healthway Medical at 17c today.  Volume, although higher, is not very much so.  Would the selling pressure continue? Where is the next support?

The MACD is plunging into negative territory, widening its distance from the signal line as it does so.  The momentum has clearly turned negative. With the lower highs we see in the MFI, it is obvious that demand is weakening.  OBV which has been sloping downwards gently took a bigger dip today, suggesting consistent distribution which accelerated today.

For sure, there is a chance price could decline further.  If it happens, the next support is at 16c, a many times tested support level in April. Given Healthway Medical's fundamentals, I feel that it is expensive even at 16c but we might see momentum oscillators entering oversold territories by then and that could bring about a brief rebound. I would pay attention to the volume as price declines.

Related post:
Healthway Medical: Second quarter results.

Saizen REIT: Sold down.

A few big transactions today, selling down Saizen REIT units.  One single transaction sold down 2m units at 15.5c.  This caused the OBV to plunge today and the MFI to sink deeper into negative territory. Distribution coupled by a reduced demand.  Not a pretty picture.

However, checking for announcements by Saizen REIT did not show any sale by insiders or substantial shareholders.  I suspect some retail investors are losing patience again.  Momentum is clearly negative as the MACD continues to decline beneath the signal line in negative territory.

At this rate, we could possibly see 15c tested as the next support. If that happens, I would buy more.

Mapletree Investments, a real-estate firm wholly owned by Singapore state investor Temasek Holdings, plans to launch a Japan property fund of around 80 billion yen (1.3 billion) this year in a bid to expand in the country’s property sector ahead of its rivals....

....Japan’s property market, the world’s second-largest and heavily leveraged, was hit hard by the onset of the global financial crisis and has yet to see a major investment since then.

But some Asian investors including wealthy Chinese individuals have begun showing an appetite for assets in Japan, whose property market is considered relatively transparent and yields stable returns.

Mapletree plans $1.3b Japan property fund
Monday, 16 August 2010

© 2010 - The Edge Singapore

Golden Agriculture: Chinese demand on the rise.

Price closed 1c lower at 57.5c today. The weakness is accompanied by a much reduced volume.  So, I am not too worried. Looking at the other indicators, we see the MFI forming a higher low, suggesting improving demand.  OBV is likewise rising, suggesting more robust accumulation activities.  The RSI has bounced off 50% which acted as support, suggesting a return of buying momentum. Any further weakness should see strong support at 55.5c as provided by the 100dMA.

The fundamentals are strong and the momentum oscillators are promising.  I would accumulate on weakness.

China's vegetable oil demand is entering a seasonal high, buoying edible oil and feedmeal prices, as the Mid-Autumn Festival and National Day holidays approach. 

"There is a supply reduction in oilseeds and this is leading to greater dependency on palm oil as supply growth is lagging behind demand," a senior trading executive at Malaysia-based major plantation company said. 

-By Shie-Lynn Lim, Dow Jones Newswires; +603 2026 1233; shie-lynn.lim@dowjones.com

Healthway Medical: Second quarter results.

Healthway Medical announced that it has entered into agreements with twelve (12) medical and dental centres in Shanghai and Hangzhou.  To operate and manage these facilities, an investment of RMB38m (or S$7.6m) is required over a period of three months. They hope to increase the number of facilities under management to more than twenty by end of this year.

At the same time, Healthway Medical also released their second quarter results and the numbers look bad.

1. Revenue compared to the same period last year has tumbled 12.3% from S$24.45m to S$21.44m.  This is worse than the first quarter when the revenue declined 6.3% compared to the same period a year ago.

2. Staff cost increased 22.9% which suggests that Healthway Medical is paying a lot more now to retain or to recruit staff.  In terms of absolute dollars, the increase from S$10.75m to S$13.2m is no small change.

3. Profit before income tax is an insignificant S$165k compared to S$5.23m in the same period last year.  This is much worse than the first quarter profit of S$1.4m.

4. Cash flow from operations is a negative S$2.3m compared to a positive S$4.05m in the same period last year.  However, it is an improvement over a negative S$4.94m in the last quarter.

5. Cash flow from financing activities is still a positive S$18.79m and the company has S$32.6m in bank deposits.

6. EPS for the quarter is 0.01c, down from 0.32c in the same quarter last year and down from 0.09c in the last quarter.

Fundamentally, Healthway Medical's numbers in the first quarter were relatively bad but they are now worse.  See second quarter statements here.

On 16 May, I blogged about Healthway Medical's first quarter results.  I said: "As an investor, to be prudent, I would continue to wait for greater clarity on whether higher earnings would follow, maintaining that the share price at current level does not offer good value."  This opinion has not changed.

Although Healthway Medical has taken another important step in its expansion plans in China, risks still exist and it remains to be seen if the management is able to execute its plans successfully and deliver value to shareholders.  With weakening revenue and rising costs at home and possible teething problems in China, investing in Healthway Medical at the current price is not for the faint hearted.

On 11 Aug, I blogged about how Healthway Medical's support at 18.5c has been compromised and that price could go lower. It is likely that 17c could be tested as a support sooner than later.

Related post:
Healthway Medical: A weak first quarter.
Healthway Medical: Support compromised.

Charts in brief: 13 Aug 10 (Part 3).

Noble: Looking at Noble's chart, the double top formation is quite obvious. If this is a valid formation, we could possibly see price declining to hit $1.20.  Top at $2.20, neckline at $1.70, target at $1.20.  A scary possibility? Price closed at $1.54, the low formed on 20 May.  Could this hold?  Well, the MFI just dipped into oversold territory.  RSI continues to sink in oversold territory.  OBV shows continuing distribution.  Price could enjoy a brief rebound and should meet with resistance at $1.64 in such an instance.

Noble cut to Hold by DBS Vickers with $1.62 target. DBS Vickers says 2Q10 results dismal, with earnings down 65% on year at US$86.6 million ($118 million).
Friday, 13 August 2010

© 2010 - The Edge Singapore

KGT: I am still interested in collecting some units of KGT.  However, the price refuses to fall below $1.10.  When I first blogged about KGT, it was at $1.06 and I said I would wait for $1.00.  Doesn't seem very probable now. However, I decided to sneak a peek at the charts. 

Well, not much to work on but notice that price has been trading below the 20dMA in recent sessions with a falling MACD. MFI has formed lower highs which suggests a falling demand. The RSI has likewise been falling suggesting increasing selling pressure over time. We could see KGT at under $1.10 again if this keeps up.  Good things come to those who wait?  Of course, if the counter goes CD soon, it could change everything.

Related post:
K-Green Trust: A stable source of passive income.

Cambridge Industrial Trust: Acquisitions and private placement.

CIT is acquiring new industrial properties in Singapore. The new purchases are to be at market valuations.

As CIT is already highly geared, to do this, it will have a private placement which will raise approximately S$37.6m, after deducting fees and expenses.  This will increase the number of units by 83,683,000. It has also secured new loan facilities, a S$50m term loan and a S$20m revolving credit from National Australia Bank Ltd.
 
By acquiring new assets valued at S$37.2m and going ahead with the private placement, CIT bumps up the value its total assets.  This is the reason why the total gearing level will reduce from 42.3% to 41.5%.

Of greater interest to existing unitholders is the effect of the acquisitions and private placement on their investment in CIT.  Will existing unitholders see greater income flow from their current investment in CIT?

Due to the acquisitions, total distributable income is expected to increase 5.7%.  However, in order to fund the acquisitions, the private placement would lead to an increase of 10.15% of units in issue.  This effectively dilutes the DPU of CIT, post acquisition. DPU is estimated to fall from 5.36c to 5.14c.  NAV per unit will also fall from 60c to 58c.

I continue to believe that AIMS AMP Capital Industrial REIT is a better investment than CIT in the world of industrial S-REITs.  The former has a stronger balance sheet and a bigger discount to NAV.  Although its yield is lower at 9.55% based on a unit price of 22.5c, it has greater room to gear up to make yield accretive acquisitions. Chances of a dilutive exercise like this one by CIT are therefore lower.

Read announcement here.

Related post:
AIMS AMP Capital Industrial REIT: Steady performance.

Charts in brief: 13 Aug 10 (Part 2).

Golden Agriculture: CPO price rose again and Golden Agriculture's share price broke resistance provided by the 20dMA at 58c. MFI registered another higher low.  OBV shows a pick up in accumulation.  RSI bounced off 50% as support.  All signs point towards optimism of market participants. Price could possibly retest 60c resistance in the next session.

Wilmar:  The market does not like the news. Wilmar's downtrend which started on 12 Jan 10 is intact.  However, connecting the lows of 21 May and 29 Jun gives us an uptrend support which approximates the rising 50dMA. So, time to buy Wilmar? The MFI has formed a lower high and the uptrend support has been broken.  Demand has clearly plunged. $6.05 is the immediate support to watch. For any brave soul who is thinking of a punt, buying close to $6.05 if the support holds is probably the strategy to adopt.

Wilmar unit to pay $80.36m for 20% stake in Kencana Agri
Friday, 13 August 2010

© 2010 - The Edge Singapore

Charts in brief: 13 Aug 10 (Part 1).

Genting SP: Broke resistance, gapped up and formed a wickless white candle on extremely high volume.  Closing at $1.46, could it go higher next week?  With such strong momentum and a flurry of BUY calls from all the research houses, we could see price going higher.  To any investor who ignored the constant SELL calls from these houses earlier, congratulations!

Citigroup upgrades Genting Singapore (G13.SG) to Buy from Sell, lifts target price to $1.55 from $0.99 after increasing FY10-FY12 earnings estimates by 20%-80% to factor in robust 2Q10 results.
Friday, 13 August 2010

© 2010 - The Edge Singapore

China Hongxing: MFI has been declining gently, no longer in overbought territory.  OBV rose today, sign of a return of accumulation activity. Volume expanded significantly as price rose today.  This is promising. Closing at 15.5c shows that the declining 200dMA is still acting as resistance. Could the rising 20dMA push the price beyond the 200dMA? Immediate support at 14.5c and immediate resistance at 16c.

Hock Lian Seng: OBV shows a trend of consistent accumulation since 21 July.  This company has strong fundamentals and, technically, the immediate support is at 28.5c, provided by the 100dMA. The rising 20dMA is on track to form a golden cross with the 100dMA soon.  This would probably strengthen the support at 28.5c. Price seems to be forming steps upwards and this reminds me of HWT's chart once upon a time.  The recent uptrend is defined by the rising 20dMA.  Could the 20dMA push price higher? Possibly. Bugbear is the falling volume.

Hock Lian Seng Holdings, the civil engineer and a building materials supplier, says it posted a 61.9% y-o-y increase in net profit attributable to shareholders to $15.2 million in 1H2010 from $9.4 million in 1H2009.
Friday, 13 August 2010

© 2010 - The Edge Singapore